Etoricoxib in pharma franchise in Odisha

Etoricoxib in PCD pharma franchise in Shimla

Etoricoxib in top pharma company in Mumbai

Etoricoxib in pcd pharma supplier in Ajmer

Etoricoxib in phama franchise company in India
Etoricoxib in phama distributor in Belagavi

Home/Products /etoricoxib-120mg-tablet

Etoscrib 120 Tablet

Composition : Etoricoxib (120mg)

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹205/-

Etoscrib 120 is a prescription medication containing 120 mg of etoricoxib, a selective COX-2 inhibitor. It is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and acute gouty arthritis. By selectively inhibiting the COX-2 enzyme, Etoscrib helps to reduce the production of prostaglandins, which are responsible for pain and inflammation in the body.

Patients taking Etoscrib may experience relief from joint pain, stiffness, and swelling, enabling better mobility and improved quality of life. This medication is often well-tolerated; however, as with any medication, some individuals may experience side effects. Common side effects include gastrointestinal issues like nausea, diarrhea, or abdominal pain, as well as potential cardiovascular effects such as elevated blood pressure. It is essential for patients to consult their healthcare provider if they notice any severe reactions or persistent side effects.

Read More

About the Product

Etoscrib 120 is a prescription medication containing 120 mg of etoricoxib, a selective COX-2 inhibitor. It is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and acute gouty arthritis. By selectively inhibiting the COX-2 enzyme, Etoscrib helps to reduce the production of prostaglandins, which are responsible for pain and inflammation in the body.

Patients taking Etoscrib may experience relief from joint pain, stiffness, and swelling, enabling better mobility and improved quality of life. This medication is often well-tolerated; however, as with any medication, some individuals may experience side effects. Common side effects include gastrointestinal issues like nausea, diarrhea, or abdominal pain, as well as potential cardiovascular effects such as elevated blood pressure. It is essential for patients to consult their healthcare provider if they notice any severe reactions or persistent side effects.

Possible gastrointestinal issues, cardiovascular effects, and skin reactions.

Pain and inflammation management in osteoarthritis, rheumatoid arthritis, and acute gout.

Use under medical supervision; not recommended for patients with certain cardiovascular conditions. Patients should adhere to their doctor’s prescribed dosage and schedule to ensure optimal efficacy while minimizing potential risks. Regular monitoring by a healthcare professional is advised, particularly for those with pre-existing health conditions or those taking other medications that could interact with Etoscrib. It is crucial to inform your healthcare provider of any other drugs or supplements you are taking to avoid adverse effects. Always read the medication guide provided with the product for comprehensive information.

Store at room temperature, away from moisture and heat.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation